Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In Italy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.464
https://www.valueinhealthjournal.com/article/S1098-3015(17)30798-2/fulltext
Title :
Cost-Effectiveness Analysis of Empagliflozin In The Treatment Of T2d With Previous Cardiovascular Disease In Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30798-2&doi=10.1016/j.jval.2017.08.464
First page :
A480
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
437